share_log

Kyverna Therapeutics | 8-K: Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

SEC ·  Nov 14 05:23
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more